SCHEMBL28906223

SCHEMBL28906223

CCOS(=O)(=O)c1ccc(C)cc1-c1ccc(Br)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.37
MAPT P10636 7/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPC1 O15118 3/20 0.36
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
RAB9A P51151 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
RECQL P46063 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALKBH3 Q96Q83 1/20 0.35
GAA P10253 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.34
ALDH1A1 P00352 5/20 0.33
HTT P42858 2/20 0.33
MAOB P27338 1/20 0.33
F2 P00734 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10440962 0.82 NPC1 (0.41) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL31453311 0.80 ALDH1A1 (0.41) ACHEMAPTMEN1KMT2ANPC1
SCHEMBL12480081 0.80 PTGS2 (0.41) MEN1KMT2ANPC1KDM4EL3MBTL1
SCHEMBL28528548 0.79 CA1 (0.35) MAPTKDM4EALDH1A1MAOALOX
SCHEMBL28702808 0.79 MAPK1 (0.34) MAPTMEN1KMT2AKDM4EL3MBTL1
SCHEMBL6703319 0.76 MAOB (0.46) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL28685303 0.76 CA2 (0.51) L3MBTL1HTT
SCHEMBL6678718 0.76 STS (0.46) L3MBTL1GAA
SCHEMBL11782542 0.75 ALDH1A1 (0.49) MAPTKMT2AKDM4EL3MBTL1SMN1; SMN2
SCHEMBL811253 0.75 TSHR (0.44) MEN1KMT2ANPC1RECQLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed